HROW vs ROST · rev $114.9M vs P/E 21, rev $22.75B
Harrow Health Inc (HROW) versus Ross Stores Inc (ROST) — a side-by-side from cached financials, not a winner call.
Harrow Health Inc (HROW) is a drug manufacturers - specialty & generic company listed on US.
Ross Stores Inc (ROST) is a apparel retail company listed on US.
Latest reported HROW revenue for 2026-06-30 was $114.9M. Net income was -$44.9M. HROW currently screens at market cap $1.28B.
Latest reported ROST revenue for 2026-01-31 was $22.75B. Net income was $2.15B. Revenue was up 7.7% from 2025-02-01 to 2026-01-31. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
HROW currently screens at market cap $1.28B. ROST currently screens at market cap $43.03B and trailing P/E 20.8.
Not investment advice. Open the HROW and ROST stock pages for the full models.
Not investment advice.